Cargando…

Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study

Apathy is prevalent in first-episode psychosis (FEP) and associated with reduced global functioning. Investigations of the trajectory of apathy and its early predictors are needed to develop new treatment interventions. We here measured the levels of apathy over the first 10 years of treatment in FE...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyngstad, Siv Hege, Gardsjord, Erlend Strand, Engen, Magnus Johan, Haatveit, Beathe, Ihler, Henrik Myhre, Wedervang-Resell, Kirsten, Simonsen, Carmen, Melle, Ingrid, Færden, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423800/
https://www.ncbi.nlm.nih.gov/pubmed/32130475
http://dx.doi.org/10.1007/s00406-020-01112-3
_version_ 1783570198057451520
author Lyngstad, Siv Hege
Gardsjord, Erlend Strand
Engen, Magnus Johan
Haatveit, Beathe
Ihler, Henrik Myhre
Wedervang-Resell, Kirsten
Simonsen, Carmen
Melle, Ingrid
Færden, Ann
author_facet Lyngstad, Siv Hege
Gardsjord, Erlend Strand
Engen, Magnus Johan
Haatveit, Beathe
Ihler, Henrik Myhre
Wedervang-Resell, Kirsten
Simonsen, Carmen
Melle, Ingrid
Færden, Ann
author_sort Lyngstad, Siv Hege
collection PubMed
description Apathy is prevalent in first-episode psychosis (FEP) and associated with reduced global functioning. Investigations of the trajectory of apathy and its early predictors are needed to develop new treatment interventions. We here measured the levels of apathy over the first 10 years of treatment in FEP and in healthy controls (HC). We recruited 198 HC and 198 FEP participants. We measured apathy with the Apathy Evaluation Scale, self-report version, psychotic symptoms with the Positive and Negative Syndrome Scale, depression with the Calgary Depression Scale for Schizophrenia, functioning with the Global Assessment of Functioning Scale, and also estimated the duration of untreated psychosis (DUP). The longitudinal development of apathy and its predictors were explored using linear mixed models analyses. Associations to functioning at 10 years were investigated using multiple hierarchical linear regression analyses. In HC, mean apathy levels were low and stable. In FEP, apathy levels decreased significantly during the first year of treatment, followed by long-term stability. High individual levels of apathy at baseline were associated with higher apathy levels during the follow-up. Long DUP and high baseline levels of depression predicted higher apathy levels at follow-ups. The effect of DUP was persistent, while the effect of baseline depression decreased over time. At 10 years, apathy was statistically significantly associated with reduced functioning. The early phase of the disorder may be critical to the development of apathy in FEP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00406-020-01112-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7423800
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-74238002020-08-18 Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study Lyngstad, Siv Hege Gardsjord, Erlend Strand Engen, Magnus Johan Haatveit, Beathe Ihler, Henrik Myhre Wedervang-Resell, Kirsten Simonsen, Carmen Melle, Ingrid Færden, Ann Eur Arch Psychiatry Clin Neurosci Original Paper Apathy is prevalent in first-episode psychosis (FEP) and associated with reduced global functioning. Investigations of the trajectory of apathy and its early predictors are needed to develop new treatment interventions. We here measured the levels of apathy over the first 10 years of treatment in FEP and in healthy controls (HC). We recruited 198 HC and 198 FEP participants. We measured apathy with the Apathy Evaluation Scale, self-report version, psychotic symptoms with the Positive and Negative Syndrome Scale, depression with the Calgary Depression Scale for Schizophrenia, functioning with the Global Assessment of Functioning Scale, and also estimated the duration of untreated psychosis (DUP). The longitudinal development of apathy and its predictors were explored using linear mixed models analyses. Associations to functioning at 10 years were investigated using multiple hierarchical linear regression analyses. In HC, mean apathy levels were low and stable. In FEP, apathy levels decreased significantly during the first year of treatment, followed by long-term stability. High individual levels of apathy at baseline were associated with higher apathy levels during the follow-up. Long DUP and high baseline levels of depression predicted higher apathy levels at follow-ups. The effect of DUP was persistent, while the effect of baseline depression decreased over time. At 10 years, apathy was statistically significantly associated with reduced functioning. The early phase of the disorder may be critical to the development of apathy in FEP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00406-020-01112-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-03-04 2020 /pmc/articles/PMC7423800/ /pubmed/32130475 http://dx.doi.org/10.1007/s00406-020-01112-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Paper
Lyngstad, Siv Hege
Gardsjord, Erlend Strand
Engen, Magnus Johan
Haatveit, Beathe
Ihler, Henrik Myhre
Wedervang-Resell, Kirsten
Simonsen, Carmen
Melle, Ingrid
Færden, Ann
Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study
title Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study
title_full Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study
title_fullStr Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study
title_full_unstemmed Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study
title_short Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study
title_sort trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423800/
https://www.ncbi.nlm.nih.gov/pubmed/32130475
http://dx.doi.org/10.1007/s00406-020-01112-3
work_keys_str_mv AT lyngstadsivhege trajectoryandearlypredictorsofapathydevelopmentinfirstepisodepsychosisandhealthycontrolsa10yearfollowupstudy
AT gardsjorderlendstrand trajectoryandearlypredictorsofapathydevelopmentinfirstepisodepsychosisandhealthycontrolsa10yearfollowupstudy
AT engenmagnusjohan trajectoryandearlypredictorsofapathydevelopmentinfirstepisodepsychosisandhealthycontrolsa10yearfollowupstudy
AT haatveitbeathe trajectoryandearlypredictorsofapathydevelopmentinfirstepisodepsychosisandhealthycontrolsa10yearfollowupstudy
AT ihlerhenrikmyhre trajectoryandearlypredictorsofapathydevelopmentinfirstepisodepsychosisandhealthycontrolsa10yearfollowupstudy
AT wedervangresellkirsten trajectoryandearlypredictorsofapathydevelopmentinfirstepisodepsychosisandhealthycontrolsa10yearfollowupstudy
AT simonsencarmen trajectoryandearlypredictorsofapathydevelopmentinfirstepisodepsychosisandhealthycontrolsa10yearfollowupstudy
AT melleingrid trajectoryandearlypredictorsofapathydevelopmentinfirstepisodepsychosisandhealthycontrolsa10yearfollowupstudy
AT færdenann trajectoryandearlypredictorsofapathydevelopmentinfirstepisodepsychosisandhealthycontrolsa10yearfollowupstudy